US Patent 7314887 Thrombopoietin activity modulating compounds and methods
Patent 7314887 was granted and assigned to Ligand Pharmaceuticals on January, 2008 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 21, 2005
Date of Patent
January 1, 2008
Patent Application Number
11256572
Patent Inventor Names
E. Adam Kallel
0
Jackline E. Dalgard
0
Jyun-Hung Chen
0
Lin Zhi
0
Matthew H. McNeill
0
Thomas Lau
0
Richard J. Penuliar
0
Todd A. Miller
0
Bao N. Nguyen
0
Daniel A. Ruppar
0
•••
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7314887 Thrombopoietin activity modulating compounds and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.